Among natural chemicals used as cancer chemo-preventive and/or chemotherapeutic agents, saponins represent one of the most promising and interesting family of compounds. In this work, we aimed to elucidate the biological effects on human cells of six saponin fractions (SFs) obtained from in vitro cultures of Astragalus verrucosus Moris, a poorly characterized species. Interestingly, SF (3) showed a strongly inhibitory effect on the proliferation of human colon adenocarcinoma cell line (HCT116) via activation of a p53-dependent apoptotic pathway. In addition, SF (3) and the other SFs did not display genotoxic activity in human peripheral lymphocytes.
Natural compounds have been always considered a source of cancer chemotherapeutic and/or chemo-preventive agents. However, due to the increasing resistance of certain tumors and severe side-effects of conventional chemotherapy (including genotoxicity and secondary cancer formation), new pharmacological molecules are required. In the last decades, advances in cancer molecular biology have identified several compounds able to inhibit the growth of cancer cells with improved efficacy and selectivity, thus leading to less toxic forms of chemotherapy [1] [2] [3] [4] [5] [6] . In this view, elucidation of the biological potential of newly natural occurring or synthetic chemical substances should be also devoted to ascertain the lack of cytotoxic/genotoxic effects, especially in non cancer cells. [7] [8] [9] .
Secondary metabolites extracted from plants belonging to the genus Astragalus were proven to possess antioxidant, immunomodulatory, and antiviral properties, this making the herbs useful in the treatment of cardiovascular, neurodegenerative, infectious diseases and cancer. From a chemical point of view, the genus includes polysaccharides, saponins, and flavonoids. These components are considered the major chemical classes contributing to the multiple bioactivities of Astragalus species, although the respective molecular mechanisms of action are not fully elucidated [10] . Saponins are bioactive molecules, mainly of plant origin, but also produced by some marine organisms and insects. Other than cell membrane permeabilization, these compounds have shown cholesterol-binding, antiviral, immunomodulatory, antimicrobial, cytostatic, and antitumor activity [1, [11] [12] [13] . Different studies reported the ability of saponins, in particular triterpenoid saponins, to inhibit the proliferation of several tumor cell lines through induction of cell cycle arrest and/or apoptosis [1,5,9,11-15].
Moreover, it has been shown that saponins can also have nongenotoxic and non-cytotoxic effects in human lymphocytes [16, 17] . In addition to be used as single active molecule, some researchers have investigated the biological efficacy of saponins against cancer cells as either total extract or combinations of two or more different compounds [12, [18] [19] [20] [21] [22] . In the present work, we aimed to elucidate the biological effects on human cells of some saponin fractions (SFs) obtained from in vitro cultures of A. verrucosus, a perennial herb located in a restricted area of Sardinia, which is a still poorly characterized species [23] [24] [25] . We therefore analyzed the tumor growth inhibitory activity of these SFs on a human colon adenocarcinoma cell line (HCT116) together with their genotoxicity in human peripheral lymphocytes.
Composition of SFs and biological activity in HCT116 cells: As shown in Table 1 , SF (1), SF (2), SF (3), SF (4), SF (5) and SF (6) are composed by different combinations of known saponins extracted from A. verrucosus (Figure 1 ). Specifically, all SFs contain Astraverrucin IV (A IV), VI (A VI) and VII (A VII), Astrailienin A (AA) and Cicloaralosyde D (CD), whereas SF (2) and SF (5) also have Astraverrucin V (AV). The highest amount of saponin was found in SF (6): 897.4 µg of CD, while the lowest amount was found in SF (5): 42.8 µg of AVI.
Promotion of cell growth is a necessary feature of all types of cancer and can be attained by abnormally activated or deregulated signalling pathways involved in cell cycle regulation [14] . We therefore evaluated the antiproliferative effect of the six SFs from A. verrucosus on HCT116 cells using the sulforhodamine B (SRB) assay. As shown in Figure 2 , only SF (3) was able to significantly affect cell growth; the concentration that causes 50% growth inhibition (GI 50 ) was 7.92 ± 0.3 µg/mL for SF (3), whereas SF (1), SF (2), SF (4), SF (5) and SF (6) showed GI 50 higher than 25 µg/mL. Doxorubicin was used as positive control and the relative GI 50 was 0.054 µg/mL. As reported elsewhere [26] , an extract that gave a GI 50 of 30 µg/mL or less was considered active. Thus, we can conclude that SF (3) strongly inhibited the proliferation of HCT116 cells, especially when compared to the GI 50 of other plant extracts presented in literature [20, 21] .
Annexin-V/PI double staining demonstrated that SF(3) tumor growth inhibitory effect on HCT116 cells was associated to the induction of apoptotic cell death. In fact, as observed in Figure 3A , 15.84 µg/mL (twice the GI 50 ) of SF (3) induced early and late apoptosis. Western blot analysis showed that the SF (3)-induced apoptosis in HCT116 cells was associated with an increase in p53 protein, up-regulation of Bax (a p53 downstream pro-apoptotic target of the Bcl-2 family), as well as occurrence of PARP cleavage (a result of caspase-3 activation) ( Figure 3B ).
In addition, flow cytometric analysis showed that SF (3) did not interfere with the progression of HCT116 cells. As shown in Figure  4 , in fact, the fraction of SF (3)-treated cells within each cell cycle stage was comparable with that of untreated cells (DMSO). All together, these findings support the notion that SF (3) is able to activate a p53-dependent apoptotic pathway.
Cytotoxicity/genotoxicity of SFs in human lymphocytes:
Additionally, using the in vitro Cytokinesis-Block Micronucleus (CBMN) assay, we assessed the cytotoxic and genotoxic effects of the SFs in peripheral lymphocytes, a non-tumor and healthy human cell system. This assay is widely and routinely used in toxicology for the assessment of the genotoxic profile of chemical compounds of environmental or occupational concern [27] . The results of the CBMN test on SF-treated human lymphocytes are shown in Table  2 . None of the selected SFs, tested up to a final concentration of 300 µg/mL, caused a significant increase in the frequencies of MN when compared to the respective untreated controls. On the other hand, MN frequency of MMC-treated cultures (positive control) was 14-20 times higher than the spontaneous MN frequencies. Interestingly, the window of cytostatic/cytotoxic effects was very narrow, as SFs started to induce appreciable cell cycle delay only at 150 µg/mL, while at 300 µg/mL we could not perform MN analysis due to a strong cell toxicity. Although the solubility of SFs in DMSO was a limiting factor, our results reasonably demonstrate that, under the present experimental conditions, the SFs 1) were not genotoxic for in vitro cultured human lymphocytes and 2) showed minimal or no cytostatic effect also at relatively high dosage. In agreement with these findings, either the total methanolic extract or the butanolic and ethyl-acetate subextracts from which SFs were isolated, assayed up to 900 or 600 µg/mL final concentration, respectively, did not cause increase in the spontaneous MN frequency (see Table 3 ).
Conclusions:
In summary, five of the tested SFs (1, 2, 4, 5, and 6) were not able to inhibit the proliferation of HCT116 cells. On the contrary, SF (3) exerts a strong anti-proliferative effect against this human cancer cell line inducing cell death via activation of a p53-dependent apoptotic pathway. Noteworthy, the anti-proliferative activity of SF (3) was associated to a lack of genotoxicity in in vitro cultured human lymphocytes. Comparing the SFs composition from a qualitative and quantitative point of view, it is interesting to observe that SF (3) is the extract containing the lowest quantity of CD together with a 1:1 ratio of AVI to AVII (Table 1) . In this regard, SF (1) and SF (5) 
Human tumor cells and growth conditions:
The p53 proficient human colon adenocarcinoma cell line, HCT116, was kindly provided by Dr. B. Vogelstein (The Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland, USA) and was routinely cultured in RPMI-1640 with ultra-glutamine medium (Lonza, VWR, Carnaxide, Portugal) supplemented with 10% foetal bovine serum (FBS) (Gibco, Alfagene, Carcavelos, Portugal) and maintained in a humidified incubator at 37 °C with 5% CO 2 in air.
Cell proliferation assay:
We performed the SRB assay as described elsewhere [28] . Briefly, HCT116 cells were plated in 96-well plates at a final density of 5.0 × 10 3 cells/well. After 24 h, the cells were treated with serial dilutions of SFs (ranging from 0 to 100 µg/mL) or Doxorubicin (0-300 nM) as positive control for 48 h. The solvent of the tested chemicals (DMSO) corresponding to the maximum concentration used in the assay (0.5%) was included as negative control. The concentration of compound that causes a 50% reduction in the net protein increase within the cells (GI 50 ) was determined.
Flow cytometric analysis: HCT116 cells were seeded in 6-well plates at a final density of 1.5 × 10 5 cells/well and incubated for 24 h. Cells were then treated with 15.84 µg/mL, twice the GI 50 concentration (2xGI 50 ), of SF (3) or DMSO only (control) for 48 h. For apoptosis analysis, cells were analyzed by flow cytometry using the Annexin V-FITC Apoptosis Detection Kit I (BD Biosciences, Enzifarma, Porto, Portugal), according to the manufacturer's instructions. As described elsewhere [29] , the distribution of apoptotic cells was identified by flow cytometer on FACSCalibur (BD Biosciences, Enzifarma, Porto, Portugal) and analyzed with the Cell Quest software (BD Biosciences, Enzifarma, Porto, Portugal). For cell cycle analysis, cells were thereafter fixed in ice-cold 70% ethanol and incubated at 37 ºC with RNase A (Sigma-Aldrich, Sintra, Portugal) at a final concentration of 20 μg/mL for 15 min, and further incubated with 50 µg/mL of propidium iodide (PI) (Sigma-Aldrich, Sintra, Portugal) for 30 min, followed by flow cytometric analysis.
Western Blot analysis:
To analyze the protein expression in HCT116 human tumor cell lines, 1.5 x 10 5 cells/well were plated in 6-well plates, allowed to adhere for 24 h, and then incubated with 15.84 µg/mL of SF (3) or DMSO only (control) for 24 h. Whole cell lysates were prepared as described elsewhere [28] . Following whole protein quantification using the Coomassie staining (Bradford, Sigma-Aldrich, Sintra, Portugal), proteins (40 µg) were electrophoresed on 10% SDS-PAGE and transferred to a Whatman nitrocellulose membrane (Protan, VWR, Carnaxide, Portugal). Membranes were blocked with 5% milk and probed with a mouse monoclonal anti-p53, anti-Bax), or anti-PARP antibodies (Santa Cruz Biotechnology, Frilabo, Porto, Portugal), followed by an antimouse horseradish-peroxidase (HRP)-conjugated secondary antibody (Santa Cruz Biotechnology, Frilabo, Porto, Portugal). For loading control, membranes were stripped and re-probed with a mouse monoclonal anti-GAPDH antibody (Santa Cruz Biotechnology, Frilabo, Porto, Portugal). The signal was detected with the ECL Amersham kit (GE Healthcare, VWR, Carnaxide, Portugal) and the Kodak GBX developer and fixer (Sigma-Aldrich, Sintra, Portugal). Band intensities were quantified using the ImageJ software.
Human lymphocytes cultures and chemical treatments:
Heparinized peripheral blood samples were obtained from healthy young non-smoking male donors. The protocol was approved by the Azienda Ospedaliero-Universitaria Pisana ethical committee. After adding 0.3 mL of whole blood to 4.7 mL of RPMI 1640 (Invitrogen, Anti-proliferative effect of Astragalus verrucosus saponin Natural Product Communications Vol. 13 (9) 2018 1109 Milano, Italy) supplemented with 20% foetal bovine serum (Invitrogen, Milano, Italy), 1.5% phytohaemagglutinin (PHA) (Invitrogen, Milano, Italy) and 1.0% penicillin/streptomycin (Invitrogen, Milano, Italy), stimulated lymphocytes were incubated and cultured at 37°C for 72 h. After performing a cytotoxicity screening, SFs were dissolved in DMSO up to 300 µg/mL final concentration and added to lymphocyte cultures after 24 h. An approximately 20-30% reduction of cell proliferation was obtained for all the SFs at 150 µg/mL. Mitomycin C (MMC) was used as positive control at 0.2 µg/mL. Control cultures not receiving chemicals were also set up according to the maximum concentration of solvent used (DMSO, not exceeding 1% final concentration).
Cytogenetic assay: Cytochalasin B (6 µg/mL; Sigma Aldrich, Milano, Italy) was added at 44 h to all culture tubes to block cell cytokinesis. As described in details elsewhere [30] , lymphocytes were harvested at the end of cell culturing by 4 min centrifugation at 2400 rpm, treated with 10 mL of 0.075 mM KC1 for a few min to lyse erythrocytes, prefixed in methanol/acetic acid 3:5, fixed in 100% methanol, washed twice in methanol/acetic acid 7:1, and dropped onto clean glass slides. The air-dried slides were then stained in 5% Giemsa. 
